New device zaps nerves to tame high blood pressure

NCT ID NCT07061054

Not yet recruiting Disease control Sponsor: Shanghai Golden Leaf MedTec Co. Ltd Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study tests a device called the Netrod renal denervation system in 20 adults with uncontrolled high blood pressure who are not taking blood pressure pills. The device uses radiofrequency energy to calm overactive kidney nerves, which may help lower blood pressure. Researchers will check safety and blood pressure changes over three months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Netrod™ renal denervation system (catheter and generator)
What this could lead to: If successful, this could offer a drug-free option to control high blood pressure, reducing the need for daily medication.
What could go wrong: This is a very small pilot study with only 20 people, so results may not apply broadly. The procedure carries risks like blood vessel damage or kidney problems.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PRIMARY HYPERTENSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

essential hypertension hypertensive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

UNCONTROLLED HYPERTENSION

Contacts and locations

Locations

Barcelona Clinic Hospital

Barcelona, Catalonia, 08036, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.